Chemours (NYSE:CC) Announces Earnings Results

Chemours (NYSE:CC) announced its quarterly earnings data on Tuesday. The specialty chemicals company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.10 by $0.01, Zacks reports. Chemours had a net margin of 1.34% and a return on equity of 29.48%.

Chemours Trading Up 3.9 %

Shares of CC stock opened at $17.49 on Wednesday. Chemours has a fifty-two week low of $15.10 and a fifty-two week high of $29.83. The firm has a market capitalization of $2.61 billion, a P/E ratio of 34.98 and a beta of 1.81. The company has a debt-to-equity ratio of 6.05, a quick ratio of 0.92 and a current ratio of 1.73. The stock’s fifty day moving average is $18.21 and its two-hundred day moving average is $18.95.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 5.72%. The ex-dividend date is Friday, February 28th. Chemours’s dividend payout ratio is currently 200.00%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Truist Financial assumed coverage on shares of Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 target price for the company. Mizuho decreased their price objective on Chemours from $22.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. Barclays upped their target price on Chemours from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 5th. The Goldman Sachs Group dropped their target price on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $25.00 price objective on shares of Chemours in a report on Thursday, December 12th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $24.11.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.